FeesSafety
Pluang+

FormFactor rated Buy with 26% upside on strong semiconductor testing growth and solid Q2 results.

Company Fundamentals
15 Sep 2026
Seeking Alpha
View Source
Bullish
FormFactor rated Buy with 26% upside on strong semiconductor testing growth and solid Q2 results.

FormFactor is rated a Buy with a 26% upside potential to a $145 price target, driven by earnings growth and a 35x earnings multiple. The company benefits from increasing semiconductor complexity, advanced memory, and optical testing, which support both revenue growth and a higher-margin product mix. In Q2 2026, FormFactor reported revenues of $258.2 million, a GAAP gross margin of 50.7%, and adjusted EPS of $0.82, showing strong momentum. Key risks include customer concentration, delays in qualifying a new Texas facility, and potential margin compression after temporary benefits end.

FormFactor earnings and growth outlook provide context for market activity. For readers following the Technology sector, here is Pluang's market snapshot as of Sep 15, 2026 13:11 WIB: of 150 priced US Technology stocks tradable on Pluang, 61 rose and 82 fell today. Notable gainers include Autodesk Inc (ADSK) at USD 228.39 with a 7.53% increase, Braze Inc (BRZE) at USD 25.60 up 6.93%, and Godaddy Inc (GDDY) at USD 104.47 rising 6.53%.

More News

Darolutamide with ADT and radiation cuts metastasis or death risk by 58% in high-risk prostate cancer patients.

Darolutamide with ADT and radiation cuts metastasis or death risk by 58% in high-risk prostate cancer patients.

Interim results from the Phase 3 DASL-HiCaP trial show that adding darolutamide to standard androgen deprivation therapy (ADT) and radiation therapy reduces the risk of metastasis or death by 58% in prostate cancer patients at high risk of recurrence...

Company Fundamentals
Bullish
2 hours ago
Anthropic's revenue jumps to $16.3B in H1 2026, up from $1.1B last year

Anthropic's revenue jumps to $16.3B in H1 2026, up from $1.1B last year

Anthropic reported a massive increase in revenue, reaching $16.3 billion in the first half of 2026 compared to just $1.1 billion in the same period last year. This surge highlights rapid growth and strong demand for its products or services. The dram...

Market News
Bullish
3 hours ago
Betterware remains a Buy with a $25 target, backed by Tupperware acquisition and strong 2026 growth outlook.

Betterware remains a Buy with a $25 target, backed by Tupperware acquisition and strong 2026 growth outlook.

Betterware is rated a Buy at around $15 per share, with a medium to long-term price target of approximately $25, supported by potential gains from acquiring Tupperware. Management forecasts revenue growth of 24-26% and an EBITDA margin near 19% for f...

Analyst Insights
Bullish
4 hours ago
Bitcoin may hit a local low mid-November, with a possible high window late October to early November.

Bitcoin may hit a local low mid-November, with a possible high window late October to early November.

Analyst Benjamin Cowen notes a chart pattern suggesting Bitcoin could reach a local low around mid-November, though no exact date or price is given. The pattern is based on price moves near the 21st of each month but is not yet a confirmed recurring ...

Technical Signals
Neutral
4 hours ago
Altcoins have a 40% chance to outperform Bitcoin this cycle, says crypto analyst Dennis Liu.

Altcoins have a 40% chance to outperform Bitcoin this cycle, says crypto analyst Dennis Liu.

Crypto analyst Dennis Liu estimates that altcoins have about a 40% chance of outperforming Bitcoin during the current market cycle. He also assigns a 50% probability that altcoins will trade sideways relative to Bitcoin, and a 10% chance they will un...

Market News
Neutral
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App